Results 11 to 20 of about 1,389,574 (187)

Crystal structure of the M 5 muscarinic acetylcholine receptor [PDF]

open access: yesProceedings of the National Academy of Sciences, 2019
Abstract The human M 5 muscarinic acetylcholine receptor (mAChR) has recently emerged as an exciting therapeutic target for treating a range of disorders, including drug addiction.
Ziva Vuckovic   +16 more
openaire   +5 more sources

Identification of a Novel Allosteric Site at the M5Muscarinic Acetylcholine Receptor

open access: yesACS Chemical Neuroscience, 2021
The M5 muscarinic acetylcholine receptor (mAChR) has emerged as an exciting therapeutic target for the treatment of addiction and behavioral disorders. This has been in part due to promising preclinical studies with the M5 mAChR selective negative allosteric modulator (NAM), ML375. The binding site of ML375 remains unknown, however, making it difficult
Wessel A. C. Burger   +13 more
openaire   +3 more sources

Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice

open access: yesNeurobiology of Disease, 2006
The M5 muscarinic acetylcholine receptor (M5R) has been shown to play a crucial role in mediating acetylcholine-dependent dilation of cerebral blood vessels.
Runa Araya   +15 more
doaj   +3 more sources

A Molecular Mechanism for Endocytic Recycling of the M5 Muscarinic Acetylcholine Receptor [PDF]

open access: yes, 2010
A thesis presented to the faculty of The Rockefeller University in partial fulfillment of the requirements for the degree of Doctor of ...
Bendor, Jacob T
openaire   +2 more sources

The M1 muscarinic acetylcholine receptor subtype is important for retinal neuron survival in aging mice [PDF]

open access: yesScientific Reports, 2019
Muscarinic acetylcholine receptors have been implicated as potential neuroprotective targets for glaucoma. We tested the hypothesis that the lack of a single muscarinic receptor subtype leads to age-dependent neuron reduction in the retinal ganglion cell
Panagiotis Laspas   +9 more
doaj   +2 more sources

All muscarinic acetylcholine receptors (M1-M5) are expressed in murine brain microvascular endothelium [PDF]

open access: yesScientific Reports, 2017
AbstractClinical and experimental studies indicate that muscarinic acetylcholine receptors are potential pharmacological targets for the treatment of neurological diseases. Although these receptors have been described in human, bovine and rat cerebral microvascular tissue, a subtype functional characterization in mouse brain endothelium is lacking ...
Radu, Beatrice Mihaela   +13 more
openaire   +6 more sources

Calcium Mobilization by Activation of M3/M5 Muscarinic Receptors in the Human Retinoblastoma

open access: yesJournal of Pharmacological Sciences, 2007
Activation of muscarinic acetylcholine receptors (mAChR) is one of the most important signal transduction pathways in the human body. In this study, we investigated the role of mAChR activation in relation to its subtypes in human retinoblastoma cell ...
Dae-Ran Kim   +8 more
doaj   +2 more sources

Muscarinic acetylcholine receptor M5 is involved in spermatogenesis through the modification of cell-cell junctions. [PDF]

open access: yesReproduction, 2021
Abstract Muscarinic acetylcholine receptor (mAChR) antagonists have been reported to decrease male fertility; however, the roles of mAChRs in spermatogenesis and the underlying mechanisms are not understood yet. During spermatogenesis, extensive remodeling between Sertoli cells and/or germ cells interfaces takes place to accommodate ...
Han X   +9 more
europepmc   +4 more sources

Xanomeline and Trospium Chloride: Mechanism of Action, Clinical, and Translational Science. [PDF]

open access: yesClin Transl Sci
ABSTRACT Xanomeline‐trospium chloride (Cobenfy, formerly KarXT) is a first‐in‐class, oral central M1/M4 muscarinic receptor agonist approved for the treatment of schizophrenia in adults. Cobenfy represents a paradigm shift by avoiding direct dopamine D2 receptor blockade and thus significantly reduces the burden of metabolic, extrapyramidal, and ...
Avila S, Chen IL.
europepmc   +2 more sources

Opioid Modulation of Major Neurotransmitter Systems: Acute, Chronic, and Withdrawal Effects. [PDF]

open access: yesEur J Neurosci
Opioids are widely used but also frequently misused drugs that affect multiple neurotransmitter systems, including dopaminergic, glutamatergic, GABAergic, serotonergic, and cholinergic pathways. Opioid‐induced neuroadaptations depend on the duration of drug exposure, with distinct changes also emerging following drug discontinuation.
Novakova D, Pritulova E, Novotny J.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy